Baxter International Inc Stock News

Investors continue to be optimistic about Baxter (BAX) due to its strong product portfolio.

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its fourth-quarter 2021 financial results on Thursday, February

Here are some MedTech stocks - Quidel (QDEL), Thermo Fisher (TMO), Baxter (BAX) and BD (BDX) - that have been quite active in the acquisition front and therefore worth investor attention.

Key Players Covered in the Home Infusion Therapy Market Research Report are Optum, Inc., Infusystem, Option Care Health Inc., Moog Inc., CareCentrix, Inc., B. Braun Melsungen AG, Lincare Holdings Inc., Baxter, Promptcare, BriovaRx Infusion Services and other key market players. Key Players Covered in the Home Infusion Therapy Market Research Report are Optum, Inc., Infusystem, Option Care Health Inc., Moog Inc., CareCentrix, Inc., B. Braun Melsungen AG, Lincare Holdings Inc., Baxter, Promptcare, BriovaRx Infusion Services and other key market players.

Key Companies in Heparin Market are Opocrin S.p.A. (Formigine, Italy), Baxter (Deerfield, U.S.), Pfizer Inc. (New York, U.S.), Bioiberica S.A.U. (Barcelona, Spain), Fresenius SE & Co. KGaA (Bad Homburg, Germany), Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (Shijiazhuang, China), B. Braun Melsungen AG (Melsungen, Germany), Dr. Reddys Laboratories Ltd. (Hyderabad, India), LEO Pharma A/S (Ballerup, Denmark), Aspen Holdings (Durban, South Africa) Key Companies in Heparin Market are Opocrin S.p.A. (Formigine, Italy), Baxter (Deerfield, U.S.), Pfizer Inc. (New York, U.S.), Bioiberica S.A.U. (Barcelona, Spain), Fresenius SE & Co. KGaA (Bad Homburg, Germany), Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (Shijiazhuang, China), B. Braun Melsungen AG (Melsungen, Germany), Dr. Reddys Laboratories Ltd. (Hyderabad, India), LEO Pharma A/S (Ballerup, Denmark), Aspen Holdings (Durban, South Africa)

Baxter International Inc. (BAX) shares closed today at 0.2% below its 52 week high of $88.01, giving the company a market cap of $44B. The stock is currently up 2.5% year-to-date, up 11.4% over the past 12 months, and up 108.1% over the past five years. This week, the Dow Jones Industrial Average rose 1.1%, and the S&P 500 rose 0.1%. Trading Activity Trading volume this week was 44.3% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.4. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 163.3% The company's stock price performance over the past 12 months lags the peer average by -6.3% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -49.8% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Although it closed slightly down today, shares of Baxter International hit a 52-week high of $88.91.

Baxter International Inc. (BAX) shares closed today at 1.1% below its 52 week high of $87.43, giving the company a market cap of $43B. The stock is currently up 10.2% year-to-date, up 10.5% over the past 12 months, and up 108.4% over the past five years. This week, the Dow Jones Industrial Average rose 2.1%, and the S&P 500 rose 2.1%. Trading Activity Trading volume this week was 43.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.4. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -15.5% The company's stock price performance over the past 12 months lags the peer average by -16.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -48.5% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Baxter International Inc. (BAX) shares closed today at 0.2% below its 52 week high of $87.37, giving the company a market cap of $43B. The stock is currently up 9.6% year-to-date, up 11.0% over the past 12 months, and up 107.7% over the past five years. This week, the Dow Jones Industrial Average rose 2.6%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 51.8% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.4. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -17.4% The company's stock price performance over the past 12 months lags the peer average by -7.4% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -48.3% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

We explain why selling the cash-covered puts and covered calls is a safer choice and earns a high income. We will discuss how to formulate an options income strategy that's sustainable and repeatable.

Worldwide ""Epidural Anesthesia Sets Market"" to develop with an amazing CAGR over the conjecture time frame from 2021-2027. The report on Epidural Anesthesia Sets furnishes the customers with a thorough investigation of pivotal driving variables, buyer conduct, development patterns, item

Related Stocks: G , AZN , STOR , LNT , MDLZ , TRP , TFC , BAX , AES , COP , EFX , GRMN , ABBV , TEL , MTB , AON , D , DE ,

This article was originally published on TipRanks.com Baxter International (BAX) is an American multinational medical products company. The post Inside Baxter’s Newly Added Risk Factors appeared first on Smarter Analyst .

Shares of Baxter International Inc. (NYSE:BAX) have been given a consensus rating of Buy by the fifteen brokerages that are presently covering the company, Marketbeat reports. Four research analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average 12 month target price among brokerages []

Baxter hoops cruise past host Wolverines